From: Potential applications of aptamers in veterinary science
Modified SELEX techniques | Principle | Advantages | References |
---|---|---|---|
Negative SELEX | Removing the nucleic acid sequences that bind to the matrix, on which the targets are attached | Increased affinity of the selected aptamers | [7] |
Counter SELEX | Removing non-specific nucleic acid sequences from the target by performing negative selection on a molecule that is structurally close to the target | More specific aptamers | [7] |
CE-SELEX | Selection on capillary electrophoresis, therefore more efficient separation of linked sequences from unbound sequences, in solution | Use of non-immobilized targets, fewer cycles required (therefore less expensive because less sample and less solvent required) | |
MonoLEX | A single selection step by affinity chromatography | Only one step, therefore much faster | [9] |
Mag-SELEX | With oligonucleotides and/or targets attached to metal beads, separation of bound and unbound sequences by a magnetic field | Use of smaller targets, easier and faster separation step | |
Microfluidic SELEX | Use of a microfluidic system | Selection can be automated, association with Mag-SELEX or CE-SELEX possible | |
HTS-SELEX | Addition of high-throughput sequencing to each round | Early identification of sequence enrichment, leading to a gain in efficiency and a decrease in the number of cycles required | |
Cell-SELEX | Cells used as targets, with a negative selection step using healthy cells | The target is a transmembrane protein or an unidentified protein specific to a cell type | |
In vivo SELEX | Selection in living organisms by injection of nuclease-resistant nucleic acids | Selection of aptamers that target a tissue and can penetrate or identify it in a living organism, identification of protein markers in a tissue | |
Spiegelmer | For chiral targets, SELEX process performed on the enantiomeric form of the target, then synthesis of the selected aptamer with l-nucleotides | More stable and nuclease-resistant aptamers | |
Chimeric SELEX | Selection of two aptamers specific of two targets, and combination in a single molecule | Aptamer that can bind to two separate targets | [5] |
Toggle-SELEX | Use of homologous targets, from different species, every other round | Aptamer with significant affinity for its target even when changing species | [5] |
Crossover-SELEX | Use of purified protein or tissue/cell as targets every other round | The selected aptamer has more chance to recognize its target in vivo | [5] |
Truncation SELEX | All probable nucleotide truncations of the selected aptamer are used to perform a new screening | The size of the final aptamer is reduced while being as much or more efficient than the initial one | [5] |
Modified SELEX | Use of modified nucleotides | Modification of aptamer properties | [5] |